2BB score and signals
OnKure Therapeutics, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 62 | High |
| Momentum | 83 | Strongly Improving |
| Financial strength | 13 | Very Weak |
| Quality | 60 | Strong |
| Risk | 41 | Moderate |
Company facts
| Headquarters | Boulder, Colorado, United States |
| Founded | 2011 |
| Employees | 45 |
| 52-week range | $2.23 – $5.38 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.4182 | — | $170,003.00 |
| 2026-08-18 | — | -0.5457 | — | $170,003.00 |
| 2026-05-05 | -1.11 | -0.7574 | $0.00 | $170,003.00 |
| 2026-03-12 | -0.99 | -1.175 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish